Anyone who pays attention to the venture capital industry has heard plenty of talk about why some VCs are abandoning medical technology investment (though there are notable exceptions). The health industry is too heavily regulated, too fraught with uncertainty and facing too many cost pressures to make investment a tantalizing proposition for lots of VCs, the thinking goes.
